Molbio Diagnostics IPO Allotment Status
Check Molbio Diagnostics Allotment Status by PAN
Enter the PAN you applied with — the result comes straight from Kfin Technologies Ltd..
Not getting a result here? You can also check Molbio Diagnostics allotment directly on the KFin Technologies portal →
Check every IPO in one tap
- 1Sign in with Google — no password, free
- 2Save your PAN — and your family's, up to 5
- 3Check any IPO — all saved PANs at once
🔒 PANs are shown masked and can be removed anytime.
Molbio Diagnostics IPO — Allotment & Listing Timeline
- IPO Open 10 Aug 2026
- IPO Close 12 Aug 2026
- Basis of Allotment 13 Aug 2026
- Refund Initiation 14 Aug 2026
- Listing Date 17 Aug 2026
Molbio Diagnostics IPO — Subscription & Allotment Odds
Based on the latest subscription figures for Molbio Diagnostics IPO (overall 70.24x subscribed). The more a category is oversubscribed, the lower each applicant's chance of allotment.
In the Retail category, about 9 in 100 applicants would get an allotment in Molbio Diagnostics IPO. Winners are picked by draw of lots and each gets 18 shares (one lot), so applying for more than the minimum does not improve retail odds.
How Many Molbio Diagnostics Retail Applicants Get Shares
Molbio Diagnostics set aside 40,69,005 shares for retail investors. Each successful applicant receives 18 shares (one lot), so the retail quota can serve at most 2,26,055 applicants. With retail subscribed 12.92x, that points to roughly 25,61,957 retail applications competing for those allotments.
Estimate from the prospectus reservation and the final subscription; the registrar's Basis of Allotment has the exact count.
Molbio Diagnostics IPO Subscription, Day by Day
Times subscribed at the close of each bidding day.
| Day | Retail | NII | QIB | Total |
|---|---|---|---|---|
| Day 1 | 0.77x | 0.73x | 1.00x | 0.83x |
| Day 2 | 3.18x | 5.21x | 1.39x | 3.11x |
| Day 3 | 12.92x | 49.79x | 186.39x | 70.24x |
Retail demand grew from 0.77x on day 1 to 12.92x by day 3 — 16.8x over the bidding window.
What Molbio Diagnostics Allottees Made on Listing Day
Molbio Diagnostics listed at ₹980.00 (+21.44% on the issue price). An applicant allotted 18 shares (one lot) was up about ₹3,114 at the listing price, before charges. The last grey market premium we recorded (₹130 on 16 Aug) pointed to about ₹937; the actual listing was ₹43 higher.
Checking Molbio Diagnostics Allotment
Enter the PAN you applied with in the box above; the check goes to Kfin Technologies Ltd., the registrar for Molbio Diagnostics IPO, which finalised the allotment on 13 Aug 2026.
How the draw of lots works is the same for every issue — see IPO Allotment Process Explained. See all recent IPO allotment results. Last updated: 13 Aug 2026, 11:09 pm IST.